Skip to main content

Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 2

Grady Wulff
February 23, 2023

Continue on to learn about the remaining stocks, Microba Life Sciences (ASX:MAP) and Monash IVF (ASX:MVF), as well as what to expect from these companies in 2023.

In this video, Dr. Tara discusses:
– (0:34) Impacts of Ferring’s FDA approval on Microba
– (5:30) Drivers behind Microba’s increase in revenue
– (7:12) What 2023 looks like for Monash IVF
– (8:39) Monash IVF’s rating
– (11:45) Monash IVF’s impact from legal action

Note: This interview was filmed on 7 February 2023.

Weekly Wrap 24 April

Jessica Amir
April 24, 2020

Morning Bell 24 April

Jessica Amir
April 24, 2020

Morning Bell 23 April

Jessica Amir
April 23, 2020

Market Update 22 April

Jessica Amir
April 22, 2020

Market Update 21 April

Jessica Amir
April 21, 2020

Market Update 20 April

Jessica Amir
April 20, 2020

Weekly Wrap 17 April

Jessica Amir
April 17, 2020

Market Update 17 April

Jessica Amir
April 17, 2020

Market Update 16 April

Jessica Amir
April 16, 2020

Morning Bell 15 April

Jessica Amir
April 15, 2020

Market Update 9 April

Jessica Amir
April 9, 2020

Weekly Wrap 9 April

Jessica Amir
April 9, 2020